
The first Lyme disease vaccine in decades may be getting close.
A new vaccine candidate showed ~73% efficacy in phase 3 data. FDA review still pending.
Lyme affects hundreds of thousands of Americans yearly, especially in endemic regions.
A prevention tool like this would be a big deal if approved.
#LymeDisease #MedTwitter
English